BLOOD PRESSURE MANAGEMENT IN PATIENTS WITH CHRONIC KIDNEY DISEASE: AN APPRAISAL AND SUMMARY OF EXISTING GUIDELINES

REFERENCES

• Brouwers MC, Kho ME, Browman GP, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ 2010; 182(18): E839–842.
   PubMed Web of Science ®Google Scholar
• European Society of Hypertension-European Society of Cardiology Guide-lines C. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21(6): 1011–1053.
   PubMed Web of Science ®Google Scholar
• The Caring for Australians with Renal Impairment guidelines 2006: prevention of progression of kidney disease, website: www.cari.org.au
   Google Scholar
• Whitworth JA, World Health Organization 15oHWG. 2003 World Health Organi-zation (WHO)/International Society of Hypertension (ISH) statement on man-agement of hypertension. J Hypertens 2003; 21(11): 1983–1992.
   PubMed Web of Science ®Google Scholar
• Mancia G, Laurent S, Agabiti-Rosei E, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009; 27(11): 2121–2158.
   PubMed Web of Science ®Google Scholar
• Daskalopoulou SS, Khan NA, Quinn RR, et al. The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. Can J Cardiol 2012; 28(3): 270–287.
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289(19): 2560–2572.
   PubMed Web of Science ®Google Scholar
• KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney International 2012; supplement 2: 337–414.
   Google Scholar
• Levin A, Hemmelgarn B, Culleton B, et al. Guidelines for the management of chronic kidney disease. CMAJ 2008; 179(11): 1154–1162.
   PubMed Web of Science ®Google Scholar
• MacGregor MS, Taal MW. Renal Association Clinical Practice Guideline on detec-tion, monitoring and management of patients with CKD. Nephron Clin Pract 2011; 118 Suppl 1: c71–c100.
   Google Scholar
• Ogihara T, Kikuchi K, Matsuoka H, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res 2009; 32(1): 3–107.
   PubMed Web of Science ®Google Scholar
• Arguedas JA, Perez MI, Wright JM. Treatment blood pressure targets for hyper-tension. Cochrane Database Syst Rev 2009(3): CD004349.
   Google Scholar
• Group JS. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS). Hypertens Res 2008; 31(12): 2115–2127.
   PubMed Web of Science ®Google Scholar
• Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008; 358(18): 1887–1898.
   PubMed Web of Science ®Google Scholar
• Group AS, Cushman WC, Evans GW, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010; 362(17): 1575–1585.
   PubMed Web of Science ®Google Scholar
• Weiner DE, Tighiouart H, Levey AS, et al. Lowest systolic blood pressure is asso-ciated with stroke in stages 3 to 4 chronic kidney disease. J Am Soc Nephrol 2007; 18(3): 960–966.
   Web of Science ®Google Scholar
• Lewis JB. Blood pressure control in chronic kidney disease: is less really more? J Am Sac Nephrol 2010; 21(7): 1086–1092.
   Web of Science ®Google Scholar
• Appel LJ, Wright JT, Jr., Greene T, et al. Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med 2010; 363(10): 918–929.
   PubMed Web of Science ®Google Scholar
• Lv J, Ehteshami P, Sarnak MJ, et al. Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis. CMAJ 2013.
   Google Scholar
• Ambrosioni E, Safar M, Degaute JP, et al. Low-dose antihypertensive therapy with 1.5 mg sustained-release indapamide: results of randomised double-blind controlled studies. European study group. J Hypertens 1998; 16(11): 1677–1684.
   Web of Science ®Google Scholar
• Krum H, Skiba M, Gilbert RE. Comparative metabolic effects of hydrochlorothi-azide and indapamide in hypertensive diabetic patients receiving ACE inhibitor therapy. Diabet Med 2003; 20(9): 708–712.
   Web of Science ®Google Scholar
• Bakris GL, Weir MR, Secic M, et al. Differential effects of calcium antagonist sub-classes on markers of nephropathy progression. Kidney Int 2004; 65(6): 1991–2002.
   PubMed Web of Science ®Google Scholar
• Dickson RC, Gaebel K, Zizzo A, et al. Self-reported physician adherence to guidelines for measuring blood pressure. J Am Board Fam Med 2013; 26(2): 215–217.
   Web of Science ®Google Scholar
• Netea RT, Lenders JW, Smits P, et al. Arm position is important for blood pres-sure measurement. J Hum Hypertens 1999; 13(2): 105–109.
   PubMed Web of Science ®Google Scholar